Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Monday’s Trending Stocks: CBS, Medivation, HPE, Boeing, Sagent Pharmaceuticals

Nichi-Iko Pharmaceutical to Acquire Sagent Pharmaceuticals

Sagent Pharmaceuticals Inc (NASDAQ:SGNT) has skyrocketed by more than 39% today after the company announced that it has agreed to be acquired by Japan’s Nichi-Iko Pharmaceutical for $736 million, or $21.75 per share in cash. The transaction has been unanimously approved by the Board of Directors of both companies. In a joint statement, Sagent Pharmaceuticals and Nichi-Iko Pharmaceutical said that the deal would bring together two generics drugmakers, creating attractive growth opportunities. Out of the over 750 active funds in our database, 12 held long positions in Sagent Pharmaceuticals Inc (NASDAQ:SGNT) at the conclusion of the first quarter.

HPE Considering the Sale of Software Assets

Investors are watching Hewlett Packard Enterprise Co (NYSE:HPE) this morning after a Bloomberg report claimed that the company is considering selling some of its software assets to trim its operations. This step, if executed, would be a part of HPE CEO Meg Whitman’s plan to reduce the company’s overall size of operations to better compete with rivals like Dell. The report claimed that the rumored selloff is expected to affect the assets which were acquired by HPE over the last decade, including Autonomy, Mercury Interactive, and Vertica Systems.

David Cohen and Harold Levy’s Iridian Asset Management is one of the notable hedge funds that we track which had a stake in Hewlett Packard Enterprise Co (NYSE:HPE) at the end of the first quarter. It had more than 27.51 million shares of the company at that time.

Follow Hewlett Packard Enterprise Co
Trade (HPE) Now!

AstraZeneca Planning to Bid for Medivation

Medivation Inc (NASDAQ:MDVN) is making noise today after a report published by the Sunday Times over the weekend claimed that London-based pharmaceutical company AstraZeneca is considering submitting a bid to acquire the company. Among the other candidates already lined up to acquire the San Francisco-based drug maker are Sanofi SA (ADR) (NYSE:SNY), Pfizer Inc. (NYSE:PFE), and Celgene Corporation (NASDAQ:CELG). The Sunday Times source added that no formal bid by AstraZeneca has been brought to the table yet.

A total of 49 hedge funds in our database were bullish on Medivation Inc (NASDAQ:MDVN) at the end of the first quarter. Fred Knoll’s Knoll Capital Management owns about 4.39 million shares of the company as of March 31.

Follow Medivation Inc. (NASDAQ:MDVN)
Trade (NASDAQ:MDVN) Now!

Disclosure: None

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.